These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 25671952)

  • 1. Factors affecting outcome of patients with multiple myeloma.
    Basit A; Siddiqui N; Hameed A; Muzaffar N; Athar S
    J Ayub Med Coll Abbottabad; 2014; 26(3):376-9. PubMed ID: 25671952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic value of the new international staging system in multiple myeloma. Comparison with Durie-Salmon staging system].
    Conté L G; Figueroa M G; Lois V V; Cabrera C ME; León R A; García L H; Rojas R H
    Rev Med Chil; 2008 Jan; 136(1):7-12. PubMed ID: 18483648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of the international staging system of multiple myeloma and its comparison with the DS and IFM staging system in 122 Chinese patients].
    Deng SH; Xu Y; Mai YJ; Wang YF; Zhao YZ; Zou DH; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2008 Apr; 29(4):217-21. PubMed ID: 18843972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presentation and survival of multiple myeloma patients in Ghana: a review of 169 cases.
    Acquah ME; Hsing AW; McGuire V; Wang S; Birmann B; Dei-Adomakoh Y
    Ghana Med J; 2019 Mar; 53(1):52-58. PubMed ID: 31138944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extent of disease burden determined with magnetic resonance imaging of the bone marrow is predictive of survival outcome in patients with multiple myeloma.
    Ailawadhi S; Abdelhalim AN; Derby L; Mashtare TL; Miller KC; Wilding GE; Alberico RA; Gottlieb R; Klippenstein DL; Lee K; Chanan-Khan AA
    Cancer; 2010 Jan; 116(1):84-92. PubMed ID: 19862816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International staging system for multiple myeloma.
    Greipp PR; San Miguel J; Durie BG; Crowley JJ; Barlogie B; Bladé J; Boccadoro M; Child JA; Avet-Loiseau H; Kyle RA; Lahuerta JJ; Ludwig H; Morgan G; Powles R; Shimizu K; Shustik C; Sonneveld P; Tosi P; Turesson I; Westin J
    J Clin Oncol; 2005 May; 23(15):3412-20. PubMed ID: 15809451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors and staging systems of multiple myeloma:
    Tao ZF; Fu WJ; Yuan ZG; Wang DX; Chen YB; Hou J
    Chin Med J (Engl); 2007 Oct; 120(19):1655-8. PubMed ID: 17935664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic kidney disease stage 5 as the prognostic complement of International Staging System for multiple myeloma.
    Hsiao LT; Yang CF; Yang SH; Gau JP; Yu YB; Hong YC; Liu CY; Liu JH; Chen PM; Chiou TJ; Tzeng CH
    Eur J Haematol; 2012 Feb; 88(2):159-66. PubMed ID: 21973045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of patients with multiple myeloma and renal failure on novel regimens.
    Soleymanian T; Soleimani A; Musavi A; Mojtahedi K; Hamid G
    Saudi J Kidney Dis Transpl; 2016 Mar; 27(2):335-40. PubMed ID: 26997388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count.
    Perosa F; Minoia C; Favoino E; Prete M; Dammacco F
    Blood Cells Mol Dis; 2009; 42(1):71-6. PubMed ID: 18996035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal Insufficiency in newly-diagnosed multiple myeloma: analysis according to International Myeloma Working Group consensus statement.
    Park S; Han B; Kim K; Kim SJ; Jang JH; Kim WS; Jung CW
    Anticancer Res; 2014 Aug; 34(8):4299-306. PubMed ID: 25075062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoiesis-stimulating agents are associated with reduced survival in patients with multiple myeloma.
    Katodritou E; Verrou E; Hadjiaggelidou C; Gastari V; Laschos K; Kontovinis L; Kapetanos D; Constantinou N; Terpos E; Zervas K
    Am J Hematol; 2008 Sep; 83(9):697-701. PubMed ID: 18626886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical features and survival of Chilean patients with multiple myeloma].
    Conté L G; Figueroa M G; Lois V V; Cabrera C ME; León R A; García L H; Rojas R H
    Rev Med Chil; 2007 Sep; 135(9):1111-7. PubMed ID: 18064364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological features and management of Pakistani patients with multiple myeloma.
    Shaheen H; Ghanghroo I; Malik I
    J Pak Med Assoc; 1999 Oct; 49(10):233-7. PubMed ID: 10647226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypercalcemia remains an adverse prognostic factor for newly diagnosed multiple myeloma patients in the era of novel antimyeloma therapies.
    Zagouri F; Kastritis E; Zomas A; Terpos E; Katodritou E; Symeonidis A; Delimpasi S; Pouli A; Vassilakopoulos TP; Michalis E; Giannouli S; Kartasis Z; Christoforidou A; Kokoviadou K; Hatzimichael E; Gika D; Megalakaki C; Papaioannou M; Kyrtsonis MC; Konstantopoulos K; Dimopoulos MA;
    Eur J Haematol; 2017 Nov; 99(5):409-414. PubMed ID: 28675766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple myeloma in elderly patients: prognostic factors and outcome.
    Anagnostopoulos A; Gika D; Symeonidis A; Zervas K; Pouli A; Repoussis P; Grigoraki V; Anagnostopoulos N; Economopoulos T; Maniatis A; Dimopoulos MA
    Eur J Haematol; 2005 Nov; 75(5):370-5. PubMed ID: 16191085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison among immunologically different subtypes of 595 untreated multiple myeloma patients in northern China.
    Zhang L; Qi JY; Qi PJ; Wang YF; Zou DH; Yao HJ; An G; Yi SH; Li Q; Qiu LG
    Clin Lymphoma Myeloma Leuk; 2010 Jun; 10(3):197-204. PubMed ID: 20511165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of vulnerability measures and their effect on survival in a real-life population of multiple myeloma patients registered at Marche Region Multiple Myeloma Registry.
    Offidani M; Corvatta L; Polloni C; Centurioni R; Visani G; Brunori M; Gentili S; Catarini M; Samori A; Blasi N; Alesiani F; Caraffa P; Burattini M; Galieni P; Fraticelli P; Ferranti M; Giuliodori L; Leoni P
    Clin Lymphoma Myeloma Leuk; 2012 Dec; 12(6):423-32. PubMed ID: 22981966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term survival and prognostic factors in stage II-III multiple myeloma treated with conventional chemotherapy].
    Pertuiset E; Chevret S; Lioté F; Delauche MC; Bardin T; Dryll A; Kuntz D
    Ann Med Interne (Paris); 1992; 143(8):519-24. PubMed ID: 1303595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of multiple myeloma patients presenting with renal failure in a university hospital in the year 2010.
    Suyanı E; Sucak GT; Erten Y; Cakar MK; Ulusal G; Yağcı M; Haznedar R
    Ren Fail; 2012; 34(2):257-62. PubMed ID: 22260636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.